Changes To Senate Drug Pricing Bill Already Made, But Grassley Mum

By John Wilkerson / February 13, 2020 at 2:48 PM
Changes to the Senate Finance drug pricing bill already have been made and the Congressional Budget Office is estimating the revisions’ impact on the budget, but Senate Finance Committee Chair Chuck Grassley remained mum on those changes Thursday (Feb. 13). The Iowa Republican estimates he needs to bring along at least 25 Republicans to make Majority Leader Mitch McConnell (R-KY) comfortable with allowing a floor vote on S. 2543, and Grassley says he is talking one-on-one with GOP senators. Grassley...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.